NAD⁺ Activation: What the Science Says About NMN, Resveratrol, and Pterostilbene

Three molecules, one capsule, one big idea — synergy! NMN to raise NAD⁺ levels. Trans-resveratrol and trans-pterostilbene, polyphenols studied for activating sirtuins — the NAD⁺-dependent enzymes — to put those levels to work. The logic snaps together cleanly. The catch: this specific combination has never been tested in a clinical trial. Plausible? Yes. Proven in humans? Not yet.

NMN and NAD⁺: Some Promising Signals

Animal studies show NMN supplementation increases NAD⁺ concentrations and improves healthspan and lifespan with great safety. In humans, a randomized controlled trial found potential for NMN supplementation to alleviate arterial stiffness, a marker of cardiovascular aging. However, human evidence on NMN for overall longevity or healthspan remains limited.

Resveratrol and Sirtuins: Mixed Evidence

Resveratrol is studied for its potential to mimic caloric restriction, a proven lifespan-extending intervention in animals that works partly via SIRT1 activation. However, a review of studies in mice concluded that the evidence for resveratrol acting as a caloric restriction mimetic is limited, with any effects appearing modest. Pterostilbene, a related compound with better oral bioavailability, is also studied for sirtuin activation, but human data is sparse.

While the individual components show some promise in animal models and early human studies, the specific combination in Magellan NAD⁺ Activation Capsules has not been tested in clinical trials. The idea of synergy is plausible but unproven. Consumers should be aware that the evidence for meaningful longevity or healthspan benefits in humans is preliminary and mixed. Effects, if any, are likely modest and require further research. Educational, not medical advice.